⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for safety profile

Every month we try and update this database with for safety profile cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)NCT02260505
Gastrointestina...
Resected Gastro...
Non-metastatic
High Risk of Re...
KIT Gene Mutati...
Imatinib mainte...
18 Years - Centre Leon Berard
Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic LeukemiaNCT02316197
Advanced Solid ...
Chronic Lymphoc...
MSC2490484A (M3...
18 Years - Merck KGaA, Darmstadt, Germany
Faslodex Post Marketing SurveillanceNCT00860561
Breast Cancer
- AstraZeneca
Faslodex Post Marketing SurveillanceNCT00860561
Breast Cancer
- AstraZeneca
Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)NCT02014831
Squamous Cell C...
Cetuximab
TIP
18 Years - Centre Leon Berard
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: